Vanda Pharmaceuticals
VNDA
A$7.18
Share price
-0.43%
Change (1 day)
-21.70%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total debt
Total debt on the balance sheet as of March 2025 : A$18.02 Million
According to Vanda Pharmaceuticals's latest financial reports the company's total debt is A$18.02 Million. A company’s total debt is the sum of all current and non-current debts.
Vanda Pharmaceuticals - Total debt on balance sheet (from 2005 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$19.87 M | 43.96% |
| 2023-12-31 | A$13.8 M | -15.69% |
| 2022-12-31 | A$16.37 M | -4.02% |
| 2021-12-31 | A$17.05 M | -3.66% |
| 2020-12-31 | A$17.7 M | -15.11% |
| 2019-12-31 | A$20.85 M | |
| 2018-12-31 | N/A | |
| 2005-12-31 | A$0.19 M | -58.91% |
| 2004-12-31 | A$0.47 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | A$47.98 B | 266,140.95% | 🇨🇭 Switzerland |
 Eli Lilly LLY | A$59.10 B | 327,834.44% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$80.18 B | 444,787.19% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | A$78.63 B | 436,162.24% | 🇺🇸 USA |
 Pfizer PFE | A$94.05 B | 521,747.59% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | N/A | N/A | 🇺🇸 USA |
 Merck MRK | A$53.47 B | 296,570.92% | 🇺🇸 USA |